|
|
 |
|
Viewing report
|
|
|
|
DNA-Vaccination against Hepatitis C. Edition No. 1
VDM Publishing House, March 2008, Pages: 56
The aim of this work was to develop a vaccination strategy against hepatitis C virus (HCV), which should induce the double benefit of an antibody production and a T cell immune response. The T cell response and the antibody production were examined in different mouse strains after immunization with a DNA-vaccine, which leads to expression of a protein, and compared with the T cell response after immunization with the protein.
Immunization with DNA alone did not induce antibody production, but was responsible for a high production of IFN-? in all mouse strains. The immunization with protein showed the opposite pattern. In all mouse strains a high antibody production was observed, but no relevant T cell response could be detected.
The future aim will be to obtain an ideal double benefit from a vaccine, and eventually to enhance the effect observed in this work by using other adjuvants and/or other antigens of the HCV.
|
|
|
|
